Market Whales and Their Recent Bets on BNTX Options
Market Whales and Their Recent Bets on BNTX Options
Investors with a lot of money to spend have taken a bearish stance on BioNTech (NASDAQ:BNTX).
擁有大量資金的投資者對BioNTech (納斯達克:BNTX) 採取了看淡的態度。
And retail traders should know.
零售交易者應該知道。
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
我們在這裏追蹤的公開期權歷史記錄上看到交易時發現了這一點。
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with BNTX, it often means somebody knows something is about to happen.
無論是機構還是富裕的個人，我們都不知道。但當BNTX發生這麼大的事情時，通常意味着有人知道即將發生什麼事情。
So how do we know what these investors just did?
那麼我們如何知道這些投資者剛剛做了什麼呢？
Today, Benzinga's options scanner spotted 19 uncommon options trades for BioNTech.
今天，Benzinga的期權掃描器發現了19次BioNTech的非常規期權交易。
This isn't normal.
這不正常。
The overall sentiment of these big-money traders is split between 31% bullish and 63%, bearish.
這些大筆資金交易者的整體情緒分爲31%看好和63%看淡。
Out of all of the special options we uncovered, 4 are puts, for a total amount of $127,500, and 15 are calls, for a total amount of $910,265.
在我們發現的所有特殊期權中，有4個看跌期權，總金額爲127,500美元，有15個看漲期權，總金額爲910,265美元。
What's The Price Target?
目標價是多少？
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $95.0 to $200.0 for BioNTech over the last 3 months.
考慮到這些合約的成交量和持倉量，看起來鯨魚們在過去3個月裏一直瞄準着BioNTech的股價區間在95.0美元到200.0美元之間。
Analyzing Volume & Open Interest
分析成交量和未平倉合約
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
這些數據可以幫助您跟蹤Coinbase Glb期權的流動性和利益，以給定的行權價格爲基礎。
This data can help you track the liquidity and interest for BioNTech's options for a given strike price.
這些數據可以幫助您跟蹤BioNTech某個行權價的期權的流動性和利息。
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of BioNTech's whale activity within a strike price range from $95.0 to $200.0 in the last 30 days.
下面，我們可以觀察該股最近30天內所有看漲和看跌期權的成交量和持倉量的變化，範圍是從95.0美元到200.0美元。
BioNTech 30-Day Option Volume & Interest Snapshot
BioNTech 30天期權成交量及利息快照
Noteworthy Options Activity:
值得注意的期權活動：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BNTX | CALL | TRADE | BEARISH | 09/20/24 | $22.6 | $20.4 | $21.1 | $95.00 | $116.0K | 2.5K | 396 |
| BNTX | CALL | SWEEP | BULLISH | 09/20/24 | $19.0 | $18.1 | $19.0 | $95.00 | $115.9K | 2.5K | 167 |
| BNTX | CALL | TRADE | BEARISH | 09/20/24 | $21.1 | $18.4 | $19.0 | $95.00 | $102.6K | 2.5K | 53 |
| BNTX | CALL | TRADE | BULLISH | 09/20/24 | $19.0 | $18.2 | $19.0 | $95.00 | $83.6K | 2.5K | 228 |
| BNTX | CALL | TRADE | BEARISH | 09/20/24 | $22.4 | $20.5 | $21.1 | $95.00 | $73.8K | 2.5K | 396 |
| 標的 | 看跌/看漲 | 交易類型 | 情緒 | 到期日 | 賣盤 | 買盤 | 價格 | 執行價格 | 總交易價格 | 未平倉合約數量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BNTX | 看漲 | 交易 | 看淡 | 09/20/24 | $22.6 | $20.4 | $21.1 | $ 95.00 | $116.0K | 2.5千 | 396 |
| BNTX | 看漲 | SWEEP | 看好 | 09/20/24 | $19.0 | $18.1 | $19.0 | $ 95.00 | 115.9K美元 | 2.5千 | 167 |
| BNTX | 看漲 | 交易 | 看淡 | 09/20/24 | $21.1 | $18.4 | $19.0 | $ 95.00 | $102.6K | 2.5千 | 53 |
| BNTX | 看漲 | 交易 | 看好 | 09/20/24 | $19.0 | $18.2 | $19.0 | $ 95.00 | $83.6K | 2.5千 | 228 |
| BNTX | 看漲 | 交易 | 看淡 | 09/20/24 | $22.4 | $20.5 | $21.1 | $ 95.00 | $73.8K | 2.5千 | 396 |
About BioNTech
生物製藥新技術是一家開創癌症和其他嚴重疾病新療法的下一代免疫治療公司。該公司利用廣泛的計算發現和治療藥物平台，快速開發新型生物製藥。其廣泛的腫瘤學產品候選品組合包括個性化和即用型基於 mRNA 的療法、創新的嵌合抗原受體 T 細胞、雙特異性免疫檢查點調節劑、有針對性的癌症抗體和小分子化合物。基於其在 mRNA 疫苗開發和內部
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.
biontech是一家總部位於德國的生物技術公司，專注於開發癌症治療藥物，包括個體化免疫療法以及包括covid在內的傳染性疾病疫苗。該公司的腫瘤學流水線包含幾類藥物，包括mRNA藥物來編碼抗原、新抗原、細胞因子和抗體、細胞療法、雙特異性抗體和抗體藥物偶聯物。biontech與幾家大型製藥公司合作，包括羅氏、禮來、輝瑞、賽諾菲安萬特和genmab。covid疫苗Comirnaty是該公司的第一個商業化產品。
Present Market Standing of BioNTech
生物-疫苗的現行市場地位
- With a volume of 492,652, the price of BNTX is up 6.46% at $111.78.
- RSI indicators hint that the underlying stock may be overbought.
- Next earnings are expected to be released in 52 days.
- 成交量爲492,652，BNTX的價格上漲6.46%，爲$111.78。
- RSI因子暗示底層股票可能被超買。
- 下一輪收益預計在52天內發佈。
What Analysts Are Saying About BioNTech
關於biontech，分析師的看法
3 market experts have recently issued ratings for this stock, with a consensus target price of $105.66666666666667.
最近有3位市場專家對這隻股票進行了評級，一致認爲目標價爲105.66666666666667美元。
- An analyst from JP Morgan has decided to maintain their Underweight rating on BioNTech, which currently sits at a price target of $91.
- In a cautious move, an analyst from HC Wainwright & Co. downgraded its rating to Buy, setting a price target of $113.
- An analyst from HC Wainwright & Co. has revised its rating downward to Buy, adjusting the price target to $113.
- JP摩根的一位分析師決定維持他們對biontech的低配評級，目前的價格目標爲91美元。
- HC Wainwright & Co.的一位分析師採取謹慎的行動，將其評級下調爲買入，並設定目標價爲113美元。
- HC Wainwright＆Co.的一位分析師將其評級下調爲買入，並將目標價調整爲113美元。
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest BioNTech options trades with real-time alerts from Benzinga Pro.
期權交易具有更高的風險和潛在回報。精明的交易者通過不斷學習，調整策略，監控多個因子，並密切關注市場動態來管理這些風險。通過Benzinga Pro的實時警報及時了解最新的biontech期權交易信息。
譯文內容由第三人軟體翻譯。